Xiangyu Wang

1.2k citations
42 papers · 877 indexed · 1 hit paper · h-index 16
Topics
RNA modifications and cancer (7 papers)Cancer-related molecular mechanisms research (5 papers)Cancer-related gene regulation (5 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Xiangyu Wang

38 papers receiving 868 citations

Hit Papers

Non-viral vectors for RNA delivery2022202620232024202250100150200

Peers

Xiangyu Wang
Comparison fields: 5 of 105
  • Molecular Biology 640
  • Cancer Research 231
  • Immunology 95
  • Biomedical Engineering 90
  • Oncology 82
Replace Riikka Kärnä with:
Riikka Kärnä Finland
Ilaria Caon Italy
Lijie Pan China
Chengyan Wang China
Baofeng Guo China
Lin Jia China
Divya Sahu United States
Anna Pastò Italy
Mayur Vilas Jain Sweden
Hamed Manoochehri Iran
Xiangyu Wang relative to Riikka Kärnä Finland Riikka Kärnä's profile →
Citations per field
00.5×
Riikka Kärnä · 1×
Citations per year

Countries citing papers authored by Xiangyu Wang

Since Specialization
Citations

This map shows the geographic impact of Xiangyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Wang more than expected).

Fields of papers citing papers by Xiangyu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Wang. The network helps show where Xiangyu Wang may publish in the future.

Co-authorship network of co-authors of Xiangyu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Wang. A scholar is included among the top collaborators of Xiangyu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Wang. Xiangyu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 0
3 8
4 3
5 8
6 4
7 6
8 1
9 7
10 27
11 11
12 15
13 17
14 9
15 46
16 9
17 31
18 27
19 30
20 55

About Xiangyu Wang

Xiangyu Wang is a scholar working on Cancer Research, Molecular Biology and Geriatrics and Gerontology, having authored 42 papers that have together received 877 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (5 papers). The work is most often cited by research in Cancer Research (231 citations), Molecular Biology (640 citations) and Immunology (95 citations). Xiangyu Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yi Yan, Xiaoyu Liu, Lu An, Jiancheng Wang, Jun Su, Xianrui Yuan, Haoyu Li, Zijin Zhao, Zhumei Cui and Zhihua Liu. Their work appears in journals such as Nature Communications, Scientific Reports and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026